| Historic (2004-11-01 to
2009-06-04) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
cancer
|
4413 |
52698.3 |
  |
| 2 |
leukemia
|
1491 |
22041.6 |
|
| 3 |
mycosis
|
950 |
16034.4 |
|
| 4 |
ovarian carcinoma
|
950 |
16034.4 |
|
| 5 |
retinoblastoma
|
950 |
16034.4 |
|
| 6 |
neuroblastoma
|
950 |
16024.5 |
|
| 7 |
Cyclophosphamide
|
950 |
15375.9 |
|
| 8 |
breast cancer
|
1100 |
14795.2 |
|
| 9 |
Leukemia
|
850 |
13623.1 |
|
| 10 |
Lymphoma Society
|
790 |
12735.3 |
|
| 11 |
Myeloma Institute for Research and Therapy
|
740 |
12274.4 |
|
| 12 |
Americans
|
920 |
11961.4 |
|
| 13 |
thalidomide
|
710 |
10942.1 |
|
| 14 |
Velcade
|
770 |
10912.3 |
|
| 15 |
Stan Winston Studio
|
630 |
10887.1 |
|
|
| 365 days (2008-06-04 to
2009-06-04) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
cancer
|
1443 |
16187.0 |
|
| 2 |
mycosis
|
950 |
14815.4 |
|
| 3 |
ovarian carcinoma
|
950 |
14815.4 |
|
| 4 |
retinoblastoma
|
950 |
14815.4 |
|
| 5 |
neuroblastoma
|
950 |
14805.4 |
|
| 6 |
leukemia
|
1051 |
14231.6 |
|
| 7 |
Cyclophosphamide
|
950 |
14156.9 |
|
| 8 |
breast cancer
|
990 |
11998.1 |
|
| 9 |
Leukemia
|
810 |
11924.5 |
|
| 10 |
Lymphoma Society
|
790 |
11721.6 |
|
| 11 |
Stan Winston Studio
|
630 |
10078.7 |
|
| 12 |
Americans
|
790 |
9275.1 |
|
| 13 |
Stan Winston
|
570 |
8344.2 |
|
| 14 |
Malibu
|
480 |
7797.8 |
|
| 15 |
HealthDay News
|
690 |
7508.5 |
|
|
| 30 days (2009-05-05 to
2009-06-04) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
cancer
|
140 |
1583.7 |
|
| 2 |
lymphoma
|
50 |
834.6 |
|
| 3 |
Hugh Stansfield
|
50 |
736.8 |
|
| 4 |
Cougar Biotechnology
|
30 |
496.7 |
|
| 5 |
James Threlfall
|
30 |
496.7 |
|
| 6 |
breast cancer
|
30 |
496.7 |
|
| 7 |
Velcade
|
30 |
492.7 |
|
| 8 |
prostate cancer
|
30 |
481.4 |
|
| 9 |
leukemia
|
30 |
479.6 |
|
| 10 |
30 years
|
30 |
437.0 |
|
| 11 |
bladder cancer
|
20 |
372.7 |
|
| 12 |
aplastic anemia
|
20 |
356.5 |
|
| 13 |
John Lemieux
|
20 |
342.7 |
|
| 14 |
Myeloma
|
20 |
342.7 |
|
| 15 |
Revlimid
|
20 |
320.7 |
|
|
